Cape Investment Advisory’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3K Buy
+105
New +$9.88K ﹤0.01% 857
2026
Q1
Sell
-58
Closed -$5.65K 710
2025
Q4
$5.65K Hold
58
﹤0.01% 875
2025
Q3
$5.14K Hold
58
0.01% 514
2025
Q2
$4.99K Hold
58
﹤0.01% 752
2025
Q1
$5.29K Hold
58
﹤0.01% 733
2024
Q4
$4.99K Hold
58
﹤0.01% 739
2024
Q3
$5.69K Hold
58
﹤0.01% 676
2024
Q2
$5.38K Sell
58
-9
-13% -$821 ﹤0.01% 645
2024
Q1
$6.24K Hold
67
﹤0.01% 616
2023
Q4
$5.81K Sell
67
-556
-89% -$46.1K ﹤0.01% 758
2023
Q3
$51.3K Hold
623
0.03% 287
2023
Q2
$52.9K Hold
623
0.03% 275
2023
Q1
$51.9K Buy
+623
New +$51.6K 0.03% 260

Other funds holding IXJ

Cape Investment Advisory's IXJ Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in iShares Global Healthcare ETF (IXJ) in Q2 2026: 105 shares worth $10.3K. The stake represents ﹤0.01% of the portfolio and ranks #857 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in IXJ as recently as Q4 2025.

Cape Investment Advisory first reported a position in IXJ in Q1 2023 and has held it in 13 quarters since. The position peaked at $52.9K in Q2 2023. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Cape Investment Advisory held 105 shares of iShares Global Healthcare ETF worth $10.3K as of Q2 2026.
  • iShares Global Healthcare ETF was a new Cape Investment Advisory position in Q2 2026.
  • iShares Global Healthcare ETF made up ﹤0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #857 holding.
  • Cape Investment Advisory first reported a position in iShares Global Healthcare ETF in Q1 2023 and has held it in 13 quarters since.
  • Cape Investment Advisory's iShares Global Healthcare ETF position peaked at $52.9K in Q2 2023.
  • 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.